EPIZYME INC (EPZM) Forecast, Price Target & Analyst Ratings
NASDAQ:EPZM • US29428V1044
1.47 USD
-0.02 (-1.34%)
At close: Aug 11, 2022
1.47 USD
0 (0%)
After Hours: 8/11/2022, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EPIZYME INC (EPZM).
Forecast Snapshot
Consensus Price Target
$3.04
+ 107.00% Upside
Next Earnings Forecast
Release DateNov 7, 2022
PeriodQ3 / 2022
EPS Estimate-$0.32
Revenue Estimate12.189M
ChartMill Buy Consensus
77.78%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.04
Upside
+ 107.00%
From current price of $1.47 to mean target of $3.04, Based on 9 analyst forecasts
Low
$1.46
Median
$1.53
High
$6.30
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
9 analysts have analysed EPZM and the average price target is 3.04 USD. This implies a price increase of 107% is expected in the next year compared to the current price of 1.47.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.78%
EPZM was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EPZM.
In the previous month the buy percentage consensus was at a similar level.
EPZM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-28 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-06-27 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-06-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-02 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-10 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2021-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-07 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-05-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-31 | Credit Suisse | Initiate | Outperform |
| 2021-02-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 7, 2022
PeriodQ3 / 2022
EPS Estimate-$0.32
Revenue Estimate12.189M
Revenue Q2Q134.36%
EPS Q2Q47.47%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
EPZM is expected to report earnings on 11/7/2022. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 12.19M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.8M 9.68% | 15.76M -33.78% | 37.427M 137.48% | 45.377M 21.24% | 74.901M 65.06% | 126.186M 68.47% | 206.31M 63.50% | 344.058M 66.77% | |
| EBITDA YoY % growth | -176.3M -38.75% | -221.44M -25.60% | -232.746M -5.11% | -119.804M 48.53% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -177.14M -38.27% | -225.42M -27.26% | -237.992M -5.58% | -186.002M 21.85% | -178.683M 3.93% | -159.071M 10.98% | -167.579M -5.35% | -180.072M -7.46% | |
| Operating Margin | -744.29% | -1,430.33% | -635.88% | -409.90% | -238.56% | -126.06% | -81.23% | -52.34% | |
| EPS YoY % growth | -1.88 -8.05% | -2.29 -21.81% | -2.41 -5.24% | -1.37 43.15% | -1.17 14.62% | -0.97 17.03% | -1.10 -13.55% | -1.28 -15.83% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 47.47% | -0.35 27.61% | -0.21 43.63% | -0.21 -2.00% | -0.21 32.04% | -0.21 39.61% | -0.18 14.29% | -0.17 19.05% | -0.16 23.81% | -0.15 28.57% |
| Revenue Q2Q % growth | 12.189M 134.36% | 13.927M 20.24% | 16.32M 87.67% | 18.462M -32.93% | 21.012M 72.38% | 23.97M 72.11% | 27.642M 69.38% | 31.518M 70.72% | 35.802M 70.39% | 40.392M 68.51% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -44.302M 30.93% | -43.862M 14.48% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
16.89%
EPS Next 5 Year
8.01%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
52.93%
Revenue Next 5 Year
57.70%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
EPIZYME INC / EPZM Forecast FAQ
What is the price target for EPZM stock?
9 analysts have analysed EPZM and the average price target is 3.04 USD. This implies a price increase of 107% is expected in the next year compared to the current price of 1.47.
Can you provide the upcoming earnings date for EPIZYME INC?
EPIZYME INC (EPZM) will report earnings on 2022-11-07.
Can you provide the consensus estimates for EPIZYME INC next earnings?
The consensus EPS estimate for the next earnings of EPIZYME INC (EPZM) is -0.32 USD and the consensus revenue estimate is 12.19M USD.
How many analysts cover EPIZYME INC (EPZM) stock?
The number of analysts covering EPIZYME INC (EPZM) is 9.